1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2021, Issue 2
  5. Article
Volume 2021, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Introduction: Individuals with serious mental illness (SMI) experience premature death, likely due to increased rates of obesity and cardiovascular disease (CVD). This study was conducted to estimate the CVD risk in a cohort of individuals with SMI receiving outpatient psychiatric services in Qatar and to assess contributory CVD risk factors.

Methods: This is a retrospective review of the electronic medical records of a cohort of outpatients with SMI attending a mental health clinic in Doha, Qatar. The CVD risk was estimated using two risk prediction tools: the American Heart Association and the American College of Cardiology (AHA/ACC) risk calculator and the World Health Organization/International Society of Hypertension (WHO/ISH) CVD risk prediction charts for the Eastern Mediterranean region. Descriptive and inferential statistics were used to analyze the demographic and clinical data. Data were analyzed using Statistical Package for the Social Sciences.

Results: Of the 346 eligible patients, 28% (n = 97) had obtainable data for the estimation of their CVD risk using both tools. Approximately one-third of the cohort (33%) were classified as high risk using the AHA/ACC risk calculator, and 13.3% were classified as intermediate to high risk using the WHO/ISH CVD risk prediction charts. Based on the AHA/ACC risk scores, among those with a high CVD risk, almost two-thirds had CVD modifiable risk factors (i.e., smoking, diabetes, dyslipidemia, and hypertension). No statistically significant difference in the CVD risk estimates was observed among individuals with a body mass index of more or lower than 30 kg/m2 ( = 0.815).

Conclusion: Based on the AHA/ACC risk calculator, approximately one-third of the study cohort had high CVD risk estimates. The WHO/ISH CVD risk prediction charts appeared to underestimate CVD risk, particularly for those identified as high risk using the AHA/ACC risk calculator. A closer alliance between psychiatrists and primary healthcare professionals to control modifiable cardiovascular risk factors among patients with SMI is necessary.

© 2021 Al-Rawi, Zolezzi, Eltorki, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2021.27
2021-09-27
2024-11-08
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2021/2/qmj.2021.27.html?itemId=/content/journals/10.5339/qmj.2021.27&mimeType=html&fmt=ahah

References

  1. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017; 16:(2):163–80.
     [Google Scholar]
  2. Lesage A, Rochette L, Émond VPelletier ESt-Laurent DBinta Diallo F et al. A surveillance system to monitor excess mortality of people with mental illness in Canada. Can J Psychiatry. 2015; 60:(12):571–9.
     [Google Scholar]
  3. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011; 10:(1):52–77.
     [Google Scholar]
  4. Pérez-Piñar M, Mathur R, Foguet Q, Ayis S, Robson J, Ayerbe L. Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders. Eur Psychiatry. 2016; 35:8–15.
     [Google Scholar]
  5. Morgan V, Waterreus A, Carr V, Castle D, Cohen M, Harvey C, et al. Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Aust N Zealand J Psych. 2016; 51:(2):124–40.
     [Google Scholar]
  6. Goldstein BI, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015; 76:(2):163–9.
     [Google Scholar]
  7. Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016; 15:(2):166–74.
     [Google Scholar]
  8. Filia SL, Baker AL, Gurvich CT, Richmond R, Kulkarni J. The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness. Drug Alcohol Rev. 2014; 33:(1):78–85.
     [Google Scholar]
  9. Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders. JAMA Psychiatry. 2014; 71:(12):1350.
     [Google Scholar]
  10. Osborn DPJ, Wright CA, Levy G, King MB, Deo R, Nazarth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry. 2008; 8:84.
     [Google Scholar]
  11. Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015; 14:(2):119–36.
     [Google Scholar]
  12. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011; 8:(2):114–26.
     [Google Scholar]
  13. Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, et al. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res. 2005; 80:(1):9–18.
     [Google Scholar]
  14. Zolezzi M, Abdulrhim S, Isleem N, Zahrah F, Eltorki Y. Medical comorbidities in patients with serious mental illness: A retrospective study of mental health patients attending an outpatient clinic in Qatar. Neuropsychiatr Dis Treat. 2017; 13:2411–8.
     [Google Scholar]
  15. Giampaoli S, Palmieri L, Mattiello A, Panico S. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2005; 15:79–85.
     [Google Scholar]
  16. World Health Organization (WHO). Global action plan for the prevention and control of NCDs 2013–2020. Geneva: WHO, 2013.
     [Google Scholar]
  17. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976; 38:(1):46–51.
     [Google Scholar]
  18. Ministry of health. Cardiovascular disease risk and management for primary care. Wellington: Ministry of Health; 2018.
     [Google Scholar]
  19. Goff DC, Lloyd-Jones DMBennett GCoady SD'agostino RBGibbons R et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63:(25 Part B):2935–59.
     [Google Scholar]
  20. WHO CVD Risk Chart Working Group. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019; 7:(10):e1332–45.
     [Google Scholar]
  21. Chen L, Wang J. Discussion of “Assessing the goodness-of-fit of logistic regression models in large samples: A modification of the Hosmer-Lemeshow test” by Giovanni Nattino, Michael L. Pennell, and Stanley Lemeshow. Biometrics 2020; 76:(2):569–71.
     [Google Scholar]
  22. Ringen P, Engh J, Birkenaes A, Dieset I, Andreassen O. Increased mortality in schizophrenia due to cardiovascular disease. A non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014; 5:137.
     [Google Scholar]
  23. Cunningham R, Poppe K, Peterson D, Every-Palmer SSoosay IJackson R. Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study. PLoS One. 2019; 14:(9):e0221521.
     [Google Scholar]
  24. Taylor VH, McIntyre RS, Gary Remington MD, Levitan RD, Sharma AM. Beyond pharmacotherapy: understanding the links between obesity and chronic mental illness. Can J Psychiatry. 2012; 57:(1):5.
     [Google Scholar]
  25. van Winkel R, van Os J, Celic I,Van Eyck D, Wampers M, Scheen A, et al. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry. 2008; 69:(8):1319–27.
     [Google Scholar]
  26. Ratliff JC, Palmese LB, Reutenauer EL, Srihari VH, Tek C. Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness. Psychosomatics. 2013; 54:(1):67–73.
     [Google Scholar]
  27. Bradshaw T, Mairs H. Obesity and serious mental ill health: A critical review of the literature. Healthcare (Basel). 2014; 2:(2):166-182.
     [Google Scholar]
  28. Garg N, Muduli S, Kapoor A, Tewari S, Kumar S, Khanna R, et al. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Indian Heart J. 2017; 69:(4):458–63.
     [Google Scholar]
  29. Osborn DP, Hardoon S, Omar RZ, Holt RI, King M, Larsen J, et al. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry. 2015; 72:(2):143–51.
     [Google Scholar]
  30. McLean G, Martin JL, Martin DJ, Guthrie B, Mercer SW, Smith DJ. Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: evidence from a national primary care database. Schizophr Res. 2014; 159:(1):176–81.
     [Google Scholar]
  31. Rigal A, Colle R, El Asmar K, Elie-Lefebvre C, Falissard B, Becquemont L, Framingham coronary score in individuals with symptoms or diagnoses of mental disorders: A review and meta-analysis. Psychiatry Res. 2018; 263:41–7.
     [Google Scholar]
  32. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithm to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017; 357:j20.
     [Google Scholar]
/content/journals/10.5339/qmj.2021.27
Loading
Evaluation of cardiovascular risk in adult psychiatric outpatients in Qatar using two risk assessment tools
Qatar Medical Journal 2021, 27 (2021); https://doi.org/10.5339/qmj.2021.27
/content/journals/10.5339/qmj.2021.27
/content/journals/10.5339/qmj.2021.27
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): cardiovascular disease, risk assessment and serious mental illness

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error